This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Lantus
  • /
  • A Study of LY2963016 Compared to Lantus� in Adult ...
Clinical trial

A Study of LY2963016 Compared to Lantus� in Adult Chinese Participants With Type 2 Diabetes Mellitus

Read time: 2 mins
Last updated:22nd Mar 2018
Identifier: NCT03338010

The purpose of this study is to compare long-acting basal insulin analog LY2963016 to Lantus® in insulin naïve adult Chinese participants with Type 2 Diabetes Mellitus (T2DM) on 2 or more oral antihyperglycemic medications (OAMs). Participants will continue their OAMs throughout the study.


Study Type: Interventional  (Clinical Trial)
Estimated Enrollment: 530 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to Lantus® in Adult Chinese Patients With Type 2 Diabetes Mellitus
Actual Study Start Date: March 22, 2018
Estimated Primary Completion Date: March 28, 2020
Estimated Study Completion Date: March 28, 2020

Arms:
- Experimental:
LY2963016
- Active Comparator: Lantus®

Category Value
Date last updated at source 2019-09-17
Study type(s) Interventional
Expected enrolment 530
Study start date 2018-03-22
Estimated primary completion date 2020-03-28

View full details